Literature DB >> 24211218

Molecular characteristics of carbapenemase-producing Enterobacteriaceae in China from 2008 to 2011: predominance of KPC-2 enzyme.

Henan Li1, Jixia Zhang2, Yingmei Liu3, Rui Zheng4, Hongbin Chen1, Xiaojuan Wang1, Zhanwei Wang1, Bin Cao3, Hui Wang5.   

Abstract

Among 228 carbapenem-nonsusceptible Enterobacteriaceae isolated in China, 65 were carbapenemase-producing Enterobacteriaceae (CPE). Among them, 41, 22, 1, and 1 produced KPC-2, IMP-4, IMP-8, and IMP-1, respectively. KPC-2-producing CPE showed higher resistance than IMP-4-producing ones. Furthermore, the first outbreak of ST11 KPC-2-producing Klebsiella pneumoniae in a Beijing second-degree hospital was identified.
© 2013.

Entities:  

Keywords:  Carbapenemase-producing Enterobacteriaceae; IMP-4; KPC-2

Mesh：

Substances：

Year:  2013        PMID： 24211218     DOI： 10.1016/j.diagmicrobio.2013.10.002

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  28 in total

1.  Implications of direct amplification for measuring antimicrobial resistance using point-of-care devices.

Authors:  M R Williams; R D Stedtfeld; H Waseem; T Stedtfeld; B Upham; W Khalife; B Etchebarne; M Hughes; J M Tiedje; S A Hashsham
Journal:  Anal Methods       Date:  2017-01-31       Impact factor: 2.896

2.  Comparative Evaluation of Four Phenotypic Methods for Detection of Class A and B Carbapenemase-Producing Enterobacteriaceae in China.

Authors:  Menglan Zhou; Danchen Wang; Timothy Kudinha; Qiwen Yang; Shuying Yu; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

3.  Emergence of KPC-2-producing Escherichia coli isolates in an urban river in Harbin, China.

Authors:  Guofeng Xu; Yue Jiang; Wei An; Hongdong Wang; Xiuying Zhang
Journal:  World J Microbiol Biotechnol       Date:  2015-07-07       Impact factor: 3.312

4.  Genome sequencing and comparative analysis of an NDM-1-producing Klebsiella pneumoniae ST15 isolated from a refugee patient.

Authors:  Tamara Salloum; Harout Arabaghian; Sahar Alousi; Edmond Abboud; Sima Tokajian
Journal:  Pathog Glob Health       Date:  2017-04-11       Impact factor: 2.894

Review 5.  Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?

Authors:  Federico Perez; Nadim G El Chakhtoura; Krisztina M Papp-Wallace; Brigid M Wilson; Robert A Bonomo
Journal:  Expert Opin Pharmacother       Date:  2016-03-09       Impact factor: 3.889

6.  Clonal dissemination of KPC-2 producing Klebsiella pneumoniae ST11 clone with high prevalence of oqxAB and rmtB in a tertiary hospital in China: results from a 3-year period.

Authors:  Li Cheng; Xiao-Li Cao; Zhi-Feng Zhang; Ming-Zhe Ning; Xue-Jing Xu; Wanqing Zhou; Jun-Hao Chen; Jin-Hua Zhang; Han Shen; Kui Zhang
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-01-19       Impact factor: 3.944

7.  Outbreak of plasmid-mediated NDM-1-producing Klebsiella pneumoniae ST105 among neonatal patients in Yunnan, China.

Authors:  Rui Zheng; Qian Zhang; Yidan Guo; Yue Feng; Li Liu; Amei Zhang; Yue Zhao; Xiaoyu Yang; Xueshan Xia
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-02-19       Impact factor: 3.944

8.  Performance evaluation of three automated identification systems in detecting carbapenem-resistant Enterobacteriaceae.

Authors:  Qingwen He; Weiyuan Chen; Liya Huang; Qili Lin; Jingling Zhang; Rui Liu; Bin Li
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-06-21       Impact factor: 3.944

9.  Clonal dissemination of KPC-2-producing Klebsiella pneumoniae ST11 and ST48 clone among multiple departments in a tertiary teaching hospital in Jiangsu Province, China.

Authors:  Bing Gu; Ruru Bi; Xiaoli Cao; Huimin Qian; Renjing Hu; Ping Ma
Journal:  Ann Transl Med       Date:  2019-12

10.  Multi-level analysis of bacteria isolated from inpatients in respiratory departments in China.

Authors:  Xiang Tang; Meng Xiao; Chao Zhuo; Yingchun Xu; Nanshan Zhong
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.